InvestorsHub Logo
Followers 13
Posts 179
Boards Moderated 0
Alias Born 05/13/2010

Re: Dr V post# 141154

Thursday, 08/07/2014 2:36:47 PM

Thursday, August 07, 2014 2:36:47 PM

Post# of 158400
I agree with DR. V. The 1$ offering of REGEN shares was one share of REGEN in lieu of 1$ of Debt. However, if REGEN is trying to raise money they will be looking for investors. If we take the consensus that most Biopharm IPO's are opening at 5-15 dollars per share and that debtors were payed at an extremely discounted rate of 1 dollar per share than we can surmise that 'early bird' INVESTORS (not former debtors) will be offered a rate of 3-13 dollars per share. This is dependent upon what is in the pipeline obviously. However seeing REGEN's name out there without BMSN (which was only attached to one of the articles today and conspicuously misspelled) means that they are starting to build a buzz at the ground roots level. Looking forward I do see an all out PR blitz ahead. Some of the possibilities are:
-REGEN opening price and IPO date announcement
-Hema I human trials a go with the FDA
-Entest news (Arthritis study complete?)
-Benitec news concerning DCellvax
-DCellVax human trials outside of the US (Aussie FDA?)
-Big Pharma funding or Grant green light?
-Chance/Community Chest (take a card and be surprised)
GLTYA!!
NoQuarter

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.